Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD) (Q28375370)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD)	scientific article

Statements

scholarly article

0 references

Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD) (English)

0 references

0 references

0 references

ventricular dysfunction

1 reference

based on heuristic

inferred from title

left ventricular dysfunction

1 reference

based on heuristic

inferred from title

2

object named as

R J Glynn

0 references

5

object named as

J Avorn

0 references

4

object named as

H Mogun

0 references

author name string

E L Knight

1

0 references

K M McIntyre

3

0 references

language of work or name

0 references

publication date

November 1999

0 references

American Heart Journal

0 references

138

0 references

5 Pt 1

0 references

849-55

0 references

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Tolerability of enalapril initiation by patients with left ventricular dysfunction: results of the medication challenge phase of the Studies of Left Ventricular Dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Adverse effects of enalapril in the Studies of Left Ventricular Dysfunction (SOLVD). SOLVD Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Deterioration in renal function associated with angiotensin converting enzyme inhibitor therapy is not always reversible

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Safety of long-term use of lisinopril for congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Acute renal failure after the use of angiotensin-converting-enzyme inhibitors in patients without renal artery stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Determinants of the renal response to ACE inhibition in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Renal function in the elderly: impact of hypertension and cardiac function

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

A randomized, double-blind, placebo-controlled trial to evaluate the effect of enalapril in patients with clinical diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Identification of risk factors predisposing to the development of functional renal insufficiency during treatment with converting-enzyme inhibitors in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Angiotensin-converting enzyme inhibitors and renal function in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

ACE Inhibitors Drug Interactions of Clinical Significance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Studies of left ventricular dysfunction (SOLVD)--rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Prediction of renal impairment in elderly patients with congestive heart failure treated with captopril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Measured versus estimated creatinine clearance in a high-functioning elderly sample: MacArthur Foundation Study of Successful Aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970009-8

7 January 2021

Identifiers

10.1016/S0002-8703(99)70009-8

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

release_z3cqxwsrtfgqjhgldzebx4vrmi

1 reference

https://api.fatcat.wiki/v0/release/z3cqxwsrtfgqjhgldzebx4vrmi

24 November 2022

based on heuristic

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28375370&oldid=1952152907"